May 8, 2025 – Today, TIME reveals the second annual TIME100 Health list recognizing the 100 most influential individuals in health.

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals get in the way of its progress. With recent indication additions, breast ...

Vas Narasimhan, the CEO of Novartis, discusses the Swiss pharmaceutical company's first-quarter earnings. MAGA divided as Trump turns on Putin 'Trash' found deep inside a Mexican cave turns out to ...

BEIJING, March 24 (Xinhua) -- Chinese Vice President Han Zheng met with Swire Pacific Limited chairman Merlin Swire, and Novartis CEO Vas Narasimhan on Monday in Beijing, who are here for the ...

TOKYO (Reuters) -Swiss pharmaceutical giant Novartis will watch "very carefully" how the reciprocal tariff policy proposed by the United States unfolds in early April, Chief Executive Vas Narasimhan ...

Chief Executive Vas Narasimhan said on Monday. U.S. President Donald Trump last month flagged potential import duties of about 25% on pharmaceuticals as part of measures affecting a range of ...

At Novartis, CEO Vas Narasimhan’s overall 2024 pay increased by 6.9% at grant value, reaching 14.2 million Swiss francs ($15.7 million), according to the company’s annual report (PDF).

The question is: Will the company take it? “We’re certainly watching the space,” Novartis CEO Vas Narasimhan, M.D., said of PD-1xVEGF bispecifics during a fourth-quarter earnings call with ...

Novartis CEO Vas Narasimhan says the pharma industry hopes to work constructively with the new Trump administration. Canada retaliates after Trump confirms 25pc tariffs Mapped: World's Largest ...

I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO of Novartis. Before I hand over to Vas, I'd just remind you that there is a Q ...

Novartis CEO Vas Narasimhan outlined projections for the company's future at the 2025 JP Morgan Healthcare conference in San Francisco on 14 January. Novartis, he said, expects peak sales of over ...